PARC ELISABETH PHARMA: what changed
PARC ELISABETH PHARMA
Largest movements
- Intangible fixed assets -€45,281
down €45,281 (-16.7%), from €271,942 to €226,661
- Receivables within one year -€31,056
down €31,056 (-73.8%), from €42,056 to €11,000
of which Trade receivables: -€42,056
- Cash -€4,256
down €4,256 (-98.2%), from €4,334 to €78
mainly Debts after one year (-€45,000) and Trade debts (-€26,905)
- Debts after one year -€45,000
down €45,000 (-22.5%), from €199,859 to €154,859
- Trade debts -€26,905
down €26,905 (-36.6%), from €73,533 to €46,627
- Profit (loss) carried forward -€12,285
down €12,285 (-20.8%), from -€59,175 to -€71,460
- Short-term financial debts +€9,853
up €9,853 (+185%), from €5,326 to €15,179
- Tax, wage and social debts -€9,748
down €9,748 (-48.3%), from €20,199 to €10,451
- Turnover +€491,912
new in 2025: €491,912
- Purchases and services +€450,533
new in 2025: €450,533
- Gross operating margin -€27,871
down €27,871 (-40.1%), from €69,418 to €41,547
- Taxes -€15,522
no longer reported in 2025 (was €15,522)
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €380,023 | €296,304 | -€83,719 | -22.0% |
| Fixed assets | 21/28 | €276,391 | €230,101 | -€46,289 | -16.7% |
| Intangible fixed assets | 21 | €271,942 | €226,661 | -€45,281 | -16.7% |
| Tangible fixed assets | 22/27 | €4,108 | €3,100 | -€1,008 | -24.5% |
| Plant, machinery and equipment | 23 | €4,108 | - | -€4,108 | |
| Furniture and vehicles | 24 | - | €3,100 | +€3,100 | |
| Financial fixed assets | 28 | €340 | €340 | = | 0.0% |
| Current assets | 29/58 | €103,632 | €66,202 | -€37,430 | -36.1% |
| Stocks and contracts in progress | 3 | €56,822 | €55,125 | -€1,697 | -3.0% |
| Stocks | 30/36 | €56,822 | €55,125 | -€1,697 | -3.0% |
| Amounts receivable within one year | 40/41 | €42,056 | €11,000 | -€31,056 | -73.8% |
| Trade receivables | 40 | €42,056 | - | -€42,056 | |
| Other amounts receivable | 41 | - | €11,000 | +€11,000 | |
| Cash at bank and in hand | 54/58 | €4,334 | €78 | -€4,256 | -98.2% |
| Deferred charges and accrued income | 490/1 | €420 | - | -€420 | |
| Total equity and liabilities | 10/49 | €380,023 | €296,304 | -€83,719 | -22.0% |
| Equity | 10/15 | -€51,115 | -€63,400 | -€12,285 | -24.0% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Contributions outside capital | 11 | - | €6,200 | +€6,200 | |
| Other | 1109/19 | - | €6,200 | +€6,200 | |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€59,175 | -€71,460 | -€12,285 | -20.8% |
| Amounts payable | 17/49 | €431,138 | €359,704 | -€71,434 | -16.6% |
| Amounts payable after more than one year | 17 | €199,859 | €154,859 | -€45,000 | -22.5% |
| Financial debts | 170/4 | €199,859 | €154,859 | -€45,000 | -22.5% |
| Amounts payable within one year | 42/48 | €229,122 | €204,845 | -€24,277 | -10.6% |
| Current portion of amounts payable after more than one year | 42 | €45,471 | €45,000 | -€471 | -1.0% |
| Financial debts | 43 | €5,326 | €15,179 | +€9,853 | +185% |
| Credit institutions | 430/8 | €5,326 | €15,179 | +€9,853 | +185% |
| Trade debts | 44 | €73,533 | €46,627 | -€26,905 | -36.6% |
| Suppliers | 440/4 | €73,533 | €46,627 | -€26,905 | -36.6% |
| Taxes, remuneration and social security | 45 | €20,199 | €10,451 | -€9,748 | -48.3% |
| Taxes | 450/3 | €20,199 | €10,451 | -€9,748 | -48.3% |
| Other amounts payable | 47/48 | €84,593 | €87,588 | +€2,995 | +3.5% |
| Accrued charges and deferred income | 492/3 | €2,157 | - | -€2,157 | |
| Turnover | 70 | - | €491,912 | +€491,912 | |
| Goods, raw materials, services and sundry goods | 60/61 | - | €450,533 | +€450,533 | |
| Remuneration, social security and pensions | 62 | - | €422 | +€422 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €46,212 | €46,289 | +€77 | +0.2% |
| Other operating charges | 640/8 | €522 | €400 | -€122 | -23.4% |
| Gross operating margin | 9900 | €69,418 | €41,547 | -€27,871 | -40.1% |
| Operating profit (loss) | 9901 | €22,684 | -€5,563 | -€28,247 | |
| Financial charges | 65/66B | €10,186 | €6,722 | -€3,464 | -34.0% |
| Recurring financial charges | 65 | €10,186 | €6,722 | -€3,464 | -34.0% |
| Profit (loss) for the period before taxes | 9903 | €12,498 | -€12,285 | -€24,783 | |
| Income taxes | 67/77 | €15,522 | - | -€15,522 | |
| Profit (loss) for the period | 9904 | -€3,024 | -€12,285 | -€9,261 | -306% |
| Profit (loss) for the period to be appropriated | 9905 | -€3,024 | -€12,285 | -€9,261 | -306% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.